Details for New Drug Application (NDA): 006695
✉ Email this page to a colleague
NDA 006695 describes MUSTARGEN, which is a drug marketed by Recordati Rare and is included in one NDA. Additional details are available on the MUSTARGEN profile page.
The generic ingredient in MUSTARGEN is mechlorethamine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the mechlorethamine hydrochloride profile page.
The generic ingredient in MUSTARGEN is mechlorethamine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the mechlorethamine hydrochloride profile page.
Summary for 006695
| Tradename: | MUSTARGEN |
| Applicant: | Recordati Rare |
| Ingredient: | mechlorethamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006695
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
